Nautilus Biotechnology is trading 6.15% higher at $2.76, with no clear company-specific announcement explaining the October 23 move.
- Its previous close was $2.60 on October 22, 2026.
- The company has scheduled its third-quarter 2026 results for before market open on October 27; that upcoming report does not establish a reason for todayβs gain.